ALFRED E. TIEFENBACHER (GmbH & Co. KG) Company Profile

08:06 EDT 20th March 2018 | BioPortfolio

AET started out in 1963 as a pioneer in the newly developing international active pharmaceutical ingredient business. In a time when there still was no direct telephone service berween the two countries, the Italian based Recordati became the first principal to be represented exclusively in Germany by AET. Today AET has over 40 best-of-breed suppliers from 13 countries around the globe, from which we can offer top-quality products at highly competitive prices. This classic API business continues to be a cornerstone of our success.


Van-der-Smissen-Straße 1
D - 22767


Phone: 49 (0) 40 - 44 18 09 - 0
Fax: 49 (0) 40 - 44 18 09 - 26

News Articles [147 Associated News Articles listed on BioPortfolio]

Retreating permafrost coasts threaten the fragile Arctic environment

(Alfred Wegener Institute, Helmholtz Centre for Polar and Marine Research) Permafrost makes up a quarter of the landmass in the Northern Hemisphere. A large EU project, coordinated by the Alfred Wegen...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Original-Research: Medigene AG (von EQUITS GmbH): Kaufen

Original-Research: Medigene AG - von EQUITS GmbH Einstufung von EQUITS GmbH zu Medigene AG Unternehmen: Medigene AG ISIN: DE000A1X3W00 Anlass der Studie: Übernahme-Angebot Empfehlung: Kaufen Kursz...

Urban One, Inc. Reports Fourth Quarter Results

Alfred C. Liggins, III, Urban One's CEO and President stated, "Overall, we produced a strong quarter from an Adjusted EBITDA standpoint, and as a Read more...

Elekta Fosters Innovation Through Nobel Center Partnership

Dr. Lars Heikensten, Executive Director of the Nobel Foundation, says: "Since Alfred Nobel wrote his will in 1895, science, humanism and peace efforts have led Read more...

NexWafe GmbH schließt Finanzierung in Höhe von 8 Millionen Euro ab

NexWafe GmbH, ein Spin-off des Fraunhofer ISE, das eine bahnbrechende Technologie zur epitaktischen Herstellung von Siliziumwafern für Photovoltaik kommerzialisiert, gab heute den Abschluss einer F...

Alfred Graham Findlay

bmj;360/mar16_12/k1203/FAF1faAlfred Graham Findlay (“Graham”) met his future wife, Catherine, while doing house officer posts at Sunderland Royal Infirmary. During two years’ national service in...

Pregnant mother in a coma wakes three months after delivery

A 33 years old woman from Victoria developed a severe case of influenza A or flu in August this year during her pregnancy with her first child. She developed severe complications from the flu and went...

PubMed Articles [28 Associated PubMed Articles listed on BioPortfolio]

Editorial: translation of the 1955 monograph by Alfred Bangerter on the treatment of amblyopia.

Emil Alfred Loeliger (Zürich 28 June 1924-Leiden 29 May 2017).

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Test results for the evaluation of a glucometer for use under hyperbaric conditions: Technical report.

This study aimed to evaluate a recently developed equipment test method by assessing the safe and accurate functioning of the Abbott Optium FreeStyle H portable blood glucose monitor for use in the Al...

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Clinical Trials [50 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

HIV-HBV Co-Infection and Liver Disease

Human immunodeficiency virus/Hepatitis B virus (HIV/HBV) co-infections are frequently observed due to shared routes of transmission, with reported figures indicating 6-9% of HIV-infected i...

Use of Implanted Microstimulators for Decreasing Spasticity and Improving Motion Following Spinal Cord Injury

The primary aims of this study are to determine the safety of the RFM System (Alfred Mann Foundation, Santa Clarita, CA) in a patient with incomplete SCI and the effect of the RFM system o...

Companies [555 Associated Companies listed on BioPortfolio]


AET started out in 1963 as a pioneer in the newly developing international active pharmaceutical ingredient business. In a time when there still was no direct telephone service berween the two countri...

Bioness, Inc.

Bioness, Inc. was established in 2004 by three of the world’s leaders in medical technology: the Alfred E. Mann Foundation for Scientific Research, Alfred E. Mann, and NESS Ltd. The Foundation is a ...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Bio-Rad Laboratories


More Information about "ALFRED E. TIEFENBACHER (GmbH & Co. KG)" on BioPortfolio

We have published hundreds of ALFRED E. TIEFENBACHER (GmbH & Co. KG) news stories on BioPortfolio along with dozens of ALFRED E. TIEFENBACHER (GmbH & Co. KG) Clinical Trials and PubMed Articles about ALFRED E. TIEFENBACHER (GmbH & Co. KG) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ALFRED E. TIEFENBACHER (GmbH & Co. KG) Companies in our database. You can also find out about relevant ALFRED E. TIEFENBACHER (GmbH & Co. KG) Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record